NCT07285356 Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
| NCT ID | NCT07285356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AC Camargo Cancer Center |
| Condition | Colon Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-10-06 |
| Primary Completion | 2026-09-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-10-06 with a primary completion date of 2026-09-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older who have provided written informed consent. * Colon adenocarcinoma with high-risk stage III (pT4pN2) or stage IV. * Oxaliplatin-based treatment in the context of localized or metastatic disease. * Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. Exclusion Criteria: * Pre-existing neuropathy. * Uncontrolled diabetes. * known glove allergies. * Prior treatment with paclitaxel, docetaxel or oxaliplatin.
Contact & Investigator
Bruna Catin Kupper, Nurse, PhD
STUDY CHAIR
AC Camarco Cancer Center
Frequently Asked Questions
Who can join the NCT07285356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07285356 currently recruiting?
Yes, NCT07285356 is actively recruiting participants. Contact the research team at virss2013@gmail.com for enrollment information.
Where is the NCT07285356 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07285356 clinical trial?
NCT07285356 is sponsored by AC Camargo Cancer Center. The principal investigator is Bruna Catin Kupper, Nurse, PhD at AC Camarco Cancer Center. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.